Prolactinoma - males

Prolactinomas are benign tumors of the pituitary gland that secrete prolactin. This hormone is best known for inducing milk production in women, but it also serves as a regulator of sexual function in men.

Causes of Prolactinoma - males

Prolactinomas are the most common pituitary tumors. Men and women are equally likely to be affected. However, smaller tumors (microadenomas) are more common in women, probably because of earlier detection.

Prolactinomas may occur alone or as part of multiple endocrine tumor syndromes.

Prolactinoma - males Symptoms

Symptoms in men include decreased sex drive, impotence, headache, visual impairment, galactorrhea (secretion of milk, which is uncommon), and symptoms of hypopituitarism (low levels of pituitary function, which result in lowered levels of thyroid or adrenal hormones).

Sexual dysfunction may result from hyperprolactinemia alone or from secondary hypogonadism (low testosterone levels).

Tests and Exams

Signs may include visual field defects, gynecomastia (enlarged breasts), galactorrhea, loss of musculature or body hair, and signs of hypothyroidism or hypoadrenalism.

Tests may show:

• Elevated prolactin
• Low testosterone
• Low FSH and LH
• MRI or CT scan showing pituitary tumor
• Abnormal visual fields

Treatment of Prolactinoma - males

Treatment often includes use of dopamine-agonist medications (bromocriptine or cabergoline), which lower levels of prolactin. In severe cases (very large or unresponsive tumors), surgery or radiation may be necessary.

Prognosis (Outlook)

Most prolactinomas respond well to medication. However, permanent visual loss or hypopituitarism (lowered function of the pituitary gland) may occur.

Potential Complications

Complications include visual loss and infertility. Some people experience nasal congestion, dizziness with standing, nausea, and fatigue, which may be side effects of dopamine-agonist medications.

When to Contact a Health Professional

Call your health care provider if you have any symptoms of prolactinoma.

Endocrine glands

Review Date: 8/6/2004
Reviewed By: Aniket R. Sidhaye, M.D., Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD. Review provided by VeriMed Healthcare Network.

_{Do not use this information for medical emergencies - Call 911. This information should not be used for the diagnosis or treatment of any medical condition. A licensed medical practitioner should always be consulted for diagnosis and treatment of any and all medical conditions. Links to other websites do not constitute endorsements and are provided for information only. Any duplication or distribution of this information is strictly prohibited.
Copyright 2012 A.D.A.M., Inc.}